Dr. Jonathan M. Morgan, MD

Dr. Morgan practices at Ear, Nose & Throat Associates in Clearwater, Florida.

Dr. Morgan's NPI, 1255350864, was assigned on July 18, 2006. Dr. Morgan graduated from College of Medicine - Tucson in 2000. Dr. Morgan holds Florida license ME88962.

Dr. Morgan's primary practice is Ear, Nose & Throat Associates, at 1320 S Ft Harrison Ave, Clearwater, FL 33756 in Pinellas County. The practice phone is (727) 216-0700.

Dr. Morgan's primary practice is Ear, Nose & Throat Associates in Clearwater, Florida. Dr. Morgan is also affiliated with Morton Plant Hospital. The medical group on file is Ear, Nose & Throat Associates. Dmand AI also links Dr. Morgan to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morgan practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Morgan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Morgan is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Morgan is licensed in Florida.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Morgan treats.

CMS data shows 2,517 Medicare services from Dr. Morgan across 21 procedure codes in 2024, for 571 Medicare patients. Medicare paid $139,093 for them.

CMS counts 571 Medicare patients who saw Dr. Morgan in 2024. The largest group is 75 to 84, with 252 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morgan's median patient age at 70, with 55% women.

In 2024, Dr. Morgan wrote 893 Medicare Part D claims for 410 patients. 95% of them were for generic drugs. CMS names the drug for 696 of them, across 14 drugs with 11 or more claims each, at $12,685 in total drug cost. In 2023, CMS named 663 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Morgan for performance year 2024, reported individually. Dr. Morgan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 61 procedures of melanoma (skin cancer) excision by Dr. Morgan, more than 88% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Morgan, published from 2023 to 2024. 2023 was the busiest year, with 2. The most frequent topics are HIV Infections, Endoscopy and Florida. Dr. Morgan's most frequent co-authors are Edward H. Farrior, FACS, MD, Sanjay Manohar Athavale, MD and Uriel R. Felsen, MD.

CMS Open Payments shows 27 general payments to Dr. Morgan from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Merz North America, Inc. paid the most, $502.

Dmand AI lists 2 awards for Dr. Morgan, most recently CMS Stage 1 EHR in 2013.

Dr. Morgan graduated from College of Medicine - Tucson in 2000. Dr. Morgan is a member of NHS.

Dr. Morgan is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.